Literature DB >> 1488395

Hydrogels for site-specific drug delivery to the colon: in vitro and in vivo degradation.

H Brøndsted1, J Kopecek.   

Abstract

Novel hydrogels based on N,N-dimethylacrylamide, N-t-butylacrylamide, and acrylic acid cross-linked with azoaromatic compounds of varying length and electron density of the azo bond were synthesized. The cross-links are degradable by microbial azoreductases present predominantly in the colon, and the gels appear to be suitable for colon-specific drug delivery. The degradability in vitro and in vivo was found to be related to the degree of swelling of the gels. The higher the degree of swelling, the higher the degradability. However, structural and electronic factors were also shown to influence reduction of azo bonds.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1488395     DOI: 10.1023/a:1015847921435

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  16 in total

1.  Biochemical and mechanical characterization of enzyme-digestible hydrogels.

Authors:  W S Shalaby; K Park
Journal:  Pharm Res       Date:  1990-08       Impact factor: 4.200

2.  The formation of an azo anion free radical metabolite during the microsomal azo reduction of sulfonazo III.

Authors:  R P Mason; F J Peterson; J L Holtzman
Journal:  Biochem Biophys Res Commun       Date:  1977-04-11       Impact factor: 3.575

3.  Hydrogels for site-specific oral drug delivery: synthesis and characterization.

Authors:  H Brøndsted; J Kopecek
Journal:  Biomaterials       Date:  1991-08       Impact factor: 12.479

Review 4.  Role of gut bacterial flora in nutrition and health: a review of recent advances in bacteriological techniques, metabolism, and factors affecting flora composition.

Authors:  J P Brown
Journal:  CRC Crit Rev Food Sci Nutr       Date:  1977-01

5.  Mechanisms of azo reduction by Streptococcus faecalis. II. The role of soluble flavins.

Authors:  R Gingell; R Walker
Journal:  Xenobiotica       Date:  1971-05       Impact factor: 1.908

Review 6.  Present and future applications of biomaterials in controlled drug delivery systems.

Authors:  R S Langer; N A Peppas
Journal:  Biomaterials       Date:  1981-10       Impact factor: 12.479

7.  Some molecular parameters influencing rate of reduction of azo compounds by intestinal microflora.

Authors:  R Walker; A J Ryan
Journal:  Xenobiotica       Date:  1971 Jul-Oct       Impact factor: 1.908

8.  A new approach to the oral administration of insulin and other peptide drugs.

Authors:  M Saffran; G S Kumar; C Savariar; J C Burnham; F Williams; D C Neckers
Journal:  Science       Date:  1986-09-05       Impact factor: 47.728

9.  5-aminosalicylic acid in a slow-release preparation: bioavailability, plasma level, and excretion in humans.

Authors:  S N Rasmussen; S Bondesen; E F Hvidberg; S H Hansen; V Binder; S Halskov; H Flachs
Journal:  Gastroenterology       Date:  1982-11       Impact factor: 22.682

10.  A polymeric drug for treatment of inflammatory bowel disease.

Authors:  J P Brown; G V McGarraugh; T M Parkinson; R E Wingard; A B Onderdonk
Journal:  J Med Chem       Date:  1983-09       Impact factor: 7.446

View more
  11 in total

1.  Evaluation of an enzyme-containing capsular shaped pulsatile drug delivery system.

Authors:  I Krögel; R Bodmeier
Journal:  Pharm Res       Date:  1999-09       Impact factor: 4.200

Review 2.  ["Targeted delivery" in the gastrointestinal tract].

Authors:  C S Leopold
Journal:  Med Klin (Munich)       Date:  1999-02-15

Review 3.  Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms.

Authors:  J B Dressman; G L Amidon; C Reppas; V P Shah
Journal:  Pharm Res       Date:  1998-01       Impact factor: 4.200

Review 4.  Oral controlled release technology for peptides: status and future prospects.

Authors:  J A Fix
Journal:  Pharm Res       Date:  1996-12       Impact factor: 4.200

5.  In Vivo Evaluation of 5-ASA Colon-Specific Tablets Using Experimental-Induced Colitis Rat Animal Model.

Authors:  Sujata P Sawarkar; S G Deshpande; A N Bajaj; V S Nikam
Journal:  AAPS PharmSciTech       Date:  2015-05-28       Impact factor: 3.246

6.  Impact of Absorption and Transport on Intelligent Therapeutics and Nano-scale Delivery of Protein Therapeutic Agents.

Authors:  Nicholas A Peppas; Daniel A Carr
Journal:  Chem Eng Sci       Date:  2009-11-16       Impact factor: 4.311

7.  The relation between swelling properties and enzymatic degradation of azo polymers designed for colon-specific drug delivery.

Authors:  G Van den Mooter; C Samyn; R Kinget
Journal:  Pharm Res       Date:  1994-12       Impact factor: 4.200

8.  Bacterial enzymes used for colon-specific drug delivery are decreased in active Crohn's disease.

Authors:  O Carrette; C Favier; C Mizon; C Neut; A Cortot; J F Colombel; J Mizon
Journal:  Dig Dis Sci       Date:  1995-12       Impact factor: 3.199

9.  In vivo evaluation of a colon-specific drug delivery system: an absorption study of theophylline from capsules coated with azo polymers in rats.

Authors:  G Van den Mooter; C Samyn; R Kinget
Journal:  Pharm Res       Date:  1995-02       Impact factor: 4.200

10.  Design and development of mixed film of pectin: ethyl cellulose for colon specific drug delivery of sennosides and triphala.

Authors:  Munira Momin; K Pundarikakshudu; S A Nagori
Journal:  Indian J Pharm Sci       Date:  2008 May-Jun       Impact factor: 0.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.